Across TCGA pan-cancer cohorts, MIR573 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR573 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR573 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR573 expression acts as an unfavorable survival marker.

UCEC and STAD are the cancer types where MIR573 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	0.231	0.768	.010	24	view →
STAD	OS	Median	II,III,IV	0.183	0.677	.004	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR573 tumor-vs-normal RNA expression · all MIR573 data types